Campylobacter Species and Guillain-Barré Syndrome

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Clinical Microbiology Reviews

• Publication date

  1998-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/CMR.11.3.555PMID 9665983PMCID PMC88896
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guillain-Barré syndrome: clinical and immunological aspects

  2004cited by this paper
• Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations

  2000influential reference
• Anti‐GD1a antibody is associated with axonal but not demyelinating forms of Guillain‐Barré syndrome

  1999cited by this paper
• Human autoimmune neuropathies.

  1998influential reference
• The lipopolysaccharide biosynthesis locus of Campylobacter jejuni 81116.

  1998cited by this paper
• Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome

  1998cited by this paper
• Workshop summary and recommendations regarding the development of Guillain-Barré syndrome following Campylobacter infection.

  1997cited by this paper
• Insights into Campylobacter jejuni-induced Guillain-Barré syndrome from the Lewis rat model of experimental allergic neuritis.

  1997cited by this paper
• Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.

  1997cited by this paper
• Campylobacter 0:41 isolation in Guillain-Barré syndrome

  1997cited by this paper
• Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome.

  1997cited by this paper
• Microbiologic approaches for studying Campylobacter species in patients with Guillain-Barré syndrome.

  1997influential reference
• Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis.

  1997cited by this paper
• Differential distribution of HLA alleles in two forms of Guillain-Barré syndrome.

  1997cited by this paper
• [Axonal form of Guillain-Barre syndrome?].

  1997cited by this paper
• Clinical and epidemiologic features of Guillain-Barré syndrome.

  1997cited by this paper
• Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome

  1997cited by this paper
• P2-reactive T cells in inflammatory demyelination of the peripheral nerve.

  1997cited by this paper
• Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains.

  1997cited by this paper
• Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain‐Barré syndrome and Fisher's syndrome

  1997cited by this paper
• Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after campylobacter infection

  1997cited by this paper
• Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome.

  1996cited by this paper
• Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome

  1996influential reference
• Campylobacter jejuni Infection and treatment for Guillain-Barré Syndrome.

  1996cited by this paper
• Pathology of the motor‐sensory axonal Guillain‐Barré syndrome

  1996influential reference
• Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3

  1996cited by this paper
• Analysis of HL and O serotypes of Campylobacter strains by the flagellin gene typing system

  1996cited by this paper
• Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy

  1996influential reference
• Gangliosides are neuronal ligands for myelin-associated glycoprotein.

  1996cited by this paper
• The use and abuse of routine stool microbiology: a College of American Pathologists Q-probes study of 601 institutions.

  1996cited by this paper
• Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma

  1996cited by this paper
• Principles of Neurology

  1996cited by this paper
• Review: Molecular mimicry of host structures by lipopolysaccharides of Campylobacter and Helicobacter spp.: implications in pathogenesis

  1996cited by this paper
• Campylobacter jejuni infection and Guillain-Barre syndrome.

  1996influential reference
• Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease.

  1996cited by this paper
• Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome.

  1995cited by this paper
• Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases.

  1995cited by this paper
• Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.

  1995influential reference
• Anti‐gal‐C antibody in autoimmune neuropathies subsequent to mycoplasma infection

  1995cited by this paper
• HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection

  1995cited by this paper
• HLA and anti-GQ1b IgG antibody in Miller Fisher syndrome and Guillain-Barré syndrome.

  1995cited by this paper
• Immunopathogenesis and treatment of the guillain–barré syndrome—part II

  1995cited by this paper
• Serum anti‐GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome

  1995cited by this paper
• Anti‐ganglioside GM1 antibodies in guillain‐barré syndrome and their relationship to Campylobacter jejuni infection

  1995influential reference
• Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice.

  1995cited by this paper
• Campylobacter jejuni infection and Guillain-Barré syndrome.

  1995cited by this paper
• Anti‐GM1 IgG antibodies and campylobacter bacteria in Guillain‐Barré syndrome: Evidence of molecular mimicry

  1995cited by this paper
• Immunopathogenesis and treatment of the guillain‐barré syndrome—part I

  1995cited by this paper
• Report of two cases

  1995cited by this paper
• The clinical correlates of high‐titer IgG anti‐GM1 antibodies

  1994cited by this paper
• Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome

  1994cited by this paper
• Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome.

  1994cited by this paper
• Electrodiagnostic studies in Guillain-Barre syndrome

  1994cited by this paper
• Identification of Gal(β1–3)GalNAc bearing glycoproteins at the nodes of ranvier in peripheral nerve

  1994cited by this paper
• There are no neurophysiologic features characteristic of “axonal” Guillain–Barré syndrome

  1994influential reference
• Antibody of patients with Guillain-Barré syndrome mediates complement-dependent cytolysis of rat Schwann cells: susceptibility to cytolysis reflects Schwann cell phenotype.

  1994cited by this paper
• Macromolecular permeability across the blood-nerve and blood-brain barriers.

  1994cited by this paper
• Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope

  1994cited by this paper
• Molecular characterization of anionic sites on the luminal front of endoneurial capillaries in sciatic nerve

  1994cited by this paper
• N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndrome

  1994cited by this paper
• Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of O antigen chains from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome.

  1994cited by this paper
• Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure

  1994influential reference
• Campylobacter jejuni strains from patiensts with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues

  1994influential reference
• Pathogenesis of axonal Guillain–Barré syndrome: Hypothesis

  1994cited by this paper
• Proceedings of the Association of British Neurologists. London, 29 September-1 October 1993. Abstracts.

  1994cited by this paper
• Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome.

  1994influential reference
• Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release.

  1994cited by this paper
• Guillain-Barré syndrome associated with IgM anti-GM1 antibody followingCampylobacter jejuni enteritis

  1994cited by this paper
• Serum anti‐GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain‐Barré syndrome

  1993cited by this paper
• Acute paralytic syndrome in three American men. Comparison with Chinese cases.

  1993cited by this paper
• Axonal form of Guillain–Barré syndrome: Evidence for macrophage‐associated demyelination

  1993cited by this paper
• Frequent presence of anti‐GQ1b antibody in Fisher's syndrome

  1993influential reference
• Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides.

  1993influential reference
• Detection of immunoglobulin A in urine specimens from children with Campylobacter-associated diarrhea by a chemiluminescent indicator-based western immunoblot assay

  1993cited by this paper
• Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues.

  1993cited by this paper
• Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain‐Barré syndrome and controls: Correlation and prognosis

  1993cited by this paper
• Association of IgG anti‐GD1a antibody with severe Guillain–Barré syndrome

  1993cited by this paper
• Serologic Evidence of Previous Campylobacter jejuni Infection in Patients with the Guillain-Barre Syndrome

  1993cited by this paper
• A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structure

  1993cited by this paper
• Localization of GM1 and Gal(β1‐3)GalNAc antigenic determinants in peripheral nerve

  1993cited by this paper
• Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms?

  1993influential reference
• Guillain-Barré syndrome in Oxfordshire: clinical features in relation to age.

  1993cited by this paper
• Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China

  1993influential reference
• Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.

  1993influential reference
• Campylobacter jejuni strains from patients with guillain‐barré syndrome belong mostly to penner serogrpup 19 and contain β‐N‐acetylglucosamine residues

  1993cited by this paper
• Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide.

  1993cited by this paper
• A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

  1992cited by this paper
• Severe acute axonal form of Guillain–Barré syndrome associated with IgG anti‐GD1a antibodies

  1992cited by this paper
• Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome.

  1992cited by this paper
• Campylobacter Jejuni: Current Status and Future Trends

  1992cited by this paper
• Clinical features of sporadic Campylobacter infections in Norway.

  1992cited by this paper
• Motor nerve inexcitability in Guillain-Barré syndrome. The spectrum of distal conduction block and axonal degeneration.

  1992cited by this paper
• The Guillain-Barré syndrome: no longer a simple concept

  1992cited by this paper
• Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.

  1992cited by this paper
• Serotype distribution of Campylobacter jejuni and Campylobacter coli isolated from hospitalized patients with diarrhea in central Australia

  1992cited by this paper
• Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome

  1992influential reference
• Local immune responses to the Campylobacter flagellin in acute Campylobacter gastrointestinal infection

  1992cited by this paper
• Myelin Gangliosides of Human Peripheral Nervous System: An Enrichment of GM1 in the Motor Nerve Myelin Isolated from Cauda Equina

  1992cited by this paper
• The use of hospital discharge data for public health surveillance of guillain‐barré syndrome

  1991cited by this paper
• HLA‐B35 and acute axonal polyneuropathy following Campylobacter infection

  1991cited by this paper

• Challenges in managing prolonged intensive care unit stay for Guillain–Barré syndrome–acute motor axonal neuropathy variant

  2026cites this paper
• Exploring the Role of Nuclear Factor Kappa B in the Immunobiology of Inflammatory Neuropathies.

  2026cites this paper
• The Growing Antibiotic Resistance of Campylobacter Species: Is There Any Link with Climate Change?

  2025cites this paper
• Functional Characterization of Two Polymerizing Glycosyltransferases for the Addition of N-Acetyl-d-galactosamine to the Capsular Polysaccharide of Campylobacter jejuni

  2025cites this paper
• Enhanced laboratory surveillance study of Campylobacter species in England

  2025cites this paper
• Axonal Versus Demyelinating Guillain-Barré Syndrome Subtypes in Critically Ill Children: Clinical and Autonomic Profiles.

  2025cites this paper
• Foodborne pathogens in raw milk: A review of risks and control measures

  2025cites this paper
• Guillain-Barré syndrome after the Zika epidemic in Colombia: A multicenter, matched case-control study

  2025cites this paper
• Association of placental manganese levels, maternal gut microbiota, and preeclampsia: a tripartite perspective

  2025cites this paper
• Is there a causal nexus between norovirus infection and Guillain-Barré syndrome: The lessons learnt from GBS outbreak in Pune, India, 2025.

  2025cites this paper
• Identification of the Polymerizing Glycosyltransferase Required for the Addition of d-Glucuronic Acid to the Capsular Polysaccharide of Campylobacter jejuni

  2025cites this paper
• Relapsing–Remitting Multiple Sclerosis Is Associated With a Dysbiotic Oral Microbiome

  2025cites this paper
• Shengjiang Xiexin Decoction ameliorates DSS-induced ulcerative colitis via activating Wnt/β-Catenin signaling to enhance epithelium renovation and modulating intestinal flora.

  2025cites this paper
• Guillain–Barré Syndrome in war-torn regions: the forgotten neurological emergency in humanitarian crises

  2025cites this paper
• A Longitudinal Study on Campylobacter spp. in an Integrated Broiler Complex in the Southeast Region of the United States: Prevalence and Phylogenetic Analysis.

  2024cites this paper
• Extracellular vesicles in the pathogenesis of Campylobacter jejuni.

  2024cites this paper
• Consortium of Lactobacillus crispatus 2029 and Ligilactobacillus salivarius 7247 Strains Shows In Vitro Bactericidal Effect on Campylobacter jejuni and, in Combination with Prebiotic, Protects Against Intestinal Barrier Dysfunction

  2024cites this paper
• Campylobacter fetus Adrenal Abscess

  2024cites this paper
• Oral treatment of human gut microbiota associated IL-10−/− mice suffering from acute campylobacteriosis with carvacrol, deferoxamine, deoxycholic acid, and 2-fucosyl-lactose

  2024cites this paper
• Activation of the l-fucose utilization cluster in Campylobacter jejuni induces proteomic changes and enhances Caco-2 cell invasion and fibronectin binding

  2024cites this paper
• Pathogenicity and virulence of Campylobacter jejuni: What do we really know?

  2024cites this paper
• Prophylactic Oral Application of Activated Charcoal Mitigates Acute Campylobacteriosis in Human Gut Microbiota-Associated IL-10−/− Mice

  2024cites this paper
• Role of Maternal Antibodies in the Protection of Broiler Chicks against Campylobacter Colonization in the First Weeks of Life

  2024cites this paper
• Metabarcoding study of potential pathogens and zoonotic risks associated with dog feces in Seoul, South Korea

  2024cites this paper
• Prognostic Value of Early Nerve Conduction Studies in Suspected Guillain-Barré Syndrome in Pediatric Age Group: An Observational Study

  2024cites this paper
• Assessment and genomic analysis of Salmonella and Campylobacter from different stages of an integrated no-antibiotics-ever (NAE) broiler complex: a longitudinal study

  2024cites this paper
• Temporal trends and regional variations in mortality related to Guillain-Barré syndrome in the United States: a retrospective study from 1999 to 2020

  2024cites this paper
• Immune-Mediated Myelopathies

  2024cites this paper
• Biosynthesis of UDP-α-N-Acetyl-d-mannosaminuronic Acid and CMP-β-N-Acetyl-d-neuraminic Acid for the Capsular Polysaccharides of Campylobacter jejuni

  2024cites this paper
• Menthol Pretreatment Alleviates Campylobacter jejuni-Induced Enterocolitis in Human Gut Microbiota-Associated IL-10−/− Mice

  2024cites this paper
• Genomic epidemiology and genetic characteristics of clinical Campylobacter species cocirculating in West Bengal, India, 2019, using whole genome analysis

  2024cites this paper
• Molecular Responses of the Eukaryotic Cell Line INT407 on the Internalized Campylobacter jejuni—The Other Side of the Coin

  2024cites this paper
• Genomic Analysis Points to Multiple Genetic Mechanisms for Non-Transformable Campylobacter jejuni ST-50

  2024cites this paper
• Intervention Strategies to Control Campylobacter at Different Stages of the Food Chain

  2023cites this paper
• Multiple coinfections and Guillain Barré syndrome following outdoor travel to the American Northeast

  2023cites this paper
• Campylobacter in Africa – A specific viewpoint

  2023cites this paper
• Structure and function of Campylobacter jejuni polynucleotide phosphorylase (PNPase): Insights into the role of this RNase in pathogenicity.

  2023cites this paper
• Fecal prevalence of Campylobacter spp. in house dogs in Lebanon: A pilot study

  2023cites this paper
• A Case of Guillain-Barré Syndrome With Multiple Causative Factors in a Young Male

  2023cites this paper
• Identification and isolation of Campylobacter jejuni and C. upsaliensis from bovine local milk, milk products, and human stool samples by molecular technique in Karbala province

  2023cites this paper
• A scoping review of factors associated with antimicrobial-resistant Campylobacter species infections in humans

  2023cites this paper
• Aerotolerance and Multi-Locus Sequence Typing of Campylobacter jejuni Isolated from Commercial Broiler Processing Plants

  2023cites this paper
• Cryogenic Media in Biomedical Applications: Current Advances, Challenges, and Future Perspectives

  2023cites this paper
• Prevalence of Campylobacter spp. in broilers in North Lebanon

  2023cites this paper
• Genomic Characterization of Antibiotic-Resistant Campylobacterales Isolated from Chilean Poultry Meat

  2023cites this paper
• Roles of Aerotolerance, Biofilm Formation, and Viable but Non-Culturable State in the Survival of Campylobacter jejuni in Poultry Processing Environments

  2022cites this paper
• Foodborne illness outbreaks linked to unpasteurised milk and relationship to changes in state laws – United States, 1998–2018

  2022cites this paper
• Functional Characterization of a HAD Phosphatase Involved in Capsular Polysaccharide Biosynthesis in Campylobacter jejuni.

  2022cites this paper
• Recurrence of a Rare Subtype of Guillain-Barré Syndrome Following a Second Dose of the Shingles Vaccine

  2022cites this paper
• Th1/Th17-mediated Immunity and Protection from Peripheral Neuropathy in Wildtype and IL10-/- BALB/c Mice Infected with a Guillain-Barré Syndrome‑associated Campylobacter jejuni Strain.

  2022cites this paper
• Differences in the Propensity of Different Antimicrobial Resistance Determinants to Be Disseminated via Transformation in Campylobacter jejuni and Campylobacter coli

  2022cites this paper
• Síndrome de Guillain-Barré / Guillain-Barré Syndrome

  2022cites this paper
• Severe bradycardia in a teenager as the initial manifestation for Guillain Barré syndrome: a case report

  2022cites this paper
• Molecular and in silico typing of the lipooligosaccharide biosynthesis gene cluster in Campylobacter jejuni and Campylobacter coli

  2022cites this paper
• Neurological Complications of COVID-19: A Review of the Literature

  2022cites this paper
• Effect of Probiotic E. coli Nissle 1917 Supplementation on the Growth Performance, Immune Responses, Intestinal Morphology, and Gut Microbes of Campylobacter jejuni Infected Chickens

  2022cites this paper
• Campylobacter Species in the Middle East

  2022cites this paper
• AntiGQ1b antibody positive with MFS/GBS overlapped syndrome with diplopia and hemiplegia onset: Case report and retrospective analysis

  2022cites this paper
• The Host Cellular Immune Response to Infection by Campylobacter Spp. and Its Role in Disease

  2021influential citation
• A new disinfectant technique for Campylobacter jejuni and spoilage bacteria on chicken skin using a high-pressure pulsed jet spray apparatus

  2021cites this paper
• Acute and Chronic Immune Neuropathies and Radiculopathies

  2021cites this paper
• Antecedent infections in Guillain‐Barré syndrome patients from south India

  2021cites this paper
• Machine learning to predict the source of campylobacteriosis using whole genome data

  2021cites this paper
• Functional and Structural Characterization of the UDP-Glucose Dehydrogenase Involved in Capsular Polysaccharide Biosynthesis from Campylobacter jejuni.

  2021cites this paper
• Characteristics of hospitalized patients during a large waterborne outbreak of Campylobacter jejuni in Norway

  2021cites this paper
• Phenotypic and Molecular Patterns of Resistance among Campylobacter coli and Campylobacter jejuni Isolates, from Pig Farms

  2021cites this paper
• Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review

  2021cites this paper
• Revisiting Campylobacter jejuni Virulence and Fitness Factors: Role in Sensing, Adapting, and Competing

  2021cites this paper
• Discovery and Functional Characterization of a Clandestine ATP-Dependent Amidoligase in the Biosynthesis of the Capsular Polysaccharide from Campylobacter jejuni.

  2021cites this paper
• Evaluation of a Campylobacter jejuni N-glycan-ExoA glycoconjugate vaccine to reduce C. jejuni colonisation in chickens.

  2021cites this paper
• Bacterial Infections of the Small and Large Intestine

  2021cites this paper
• Genomic Relatedness, Antibiotic Resistance and Virulence Traits of Campylobacter jejuni HS19 Isolates From Cattle in China Indicate Pathogenic Potential

  2021cites this paper
• Biomolecule sulphation and novel methylations related to Guillain-Barré syndrome-associated Campylobacter jejuni serotype HS:19

  2021cites this paper
• Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literature

  2021cites this paper
• Myocarditis in a Pediatric Patient with Campylobacter Enteritis: A Case Report and Literature Review

  2021cites this paper
• Functional Characterization of Two PLP-Dependent Enzymes Involved in Capsular Polysaccharide Biosynthesis from Campylobacter jejuni.

  2021cites this paper
• Chemoenzymatic Synthesis of Campylobacter jejuni Lipo­ oligosaccharide Core Domains to Examine Guillain–Barré Syndrome Serum Antibody Specificities

  2021cites this paper
• Campylobacter in Poultry and Other Birds

  2021cites this paper
• Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort.

  2020cites this paper
• Atypical Descending Paralysis in Miller Fisher Syndrome: A Rare Variant of Guillain-Barre Syndrome

  2020cites this paper
• Evaluation of chemical treatment combined with vacuum and ultrasonication with a water resonance system for reducing Campylobacter on naturally contaminated chicken carcasses

  2020cites this paper
• Genotyping and Antimicrobial Resistance of Campylobacter Jejuni: A Review

  2020cites this paper
• The Wild Mouse (Micromys minutus): Reservoir of a Novel Campylobacter jejuni Strain

  2020cites this paper
• Causality Assessment Guidelines for Adverse Events Following Immunization with a Focus on Guillain–Barré Syndrome

  2020cites this paper
• Advanced Methods for Isolating from and Confirming Campylobacter spp. in Milk and Dairy Products: Review

  2020cites this paper
• Chemoenzymatic Synthesis of Campylobacter jejuni Lipo-oligosaccharide Core Domains to Examine Guillain-Barré Syndrome Serum Antibody Specificities.

  2020cites this paper
• Rapid detection & quantitation of Campylobacter jejuni/coli in processing

  2020cites this paper
• Comparison of Campylobacter jejuni Slaughterhouse and Surface-Water Isolates Indicates Better Adaptation of Slaughterhouse Isolates to the Chicken Host Environment

  2020cites this paper
• The structure of the UDP-Glc/GlcNAc 4-epimerase from the human pathogen Campylobacter jejuni

  2020cites this paper
• Multilocus Sequence Types and Antimicrobial Resistance of Campylobacter jejuni and C. coli Isolates of Human Patients From Beijing, China, 2017–2018

  2020cites this paper
• Horizontal genetic exchange of chromosomally encoded markers between Campylobacter jejuni cells

  2020cites this paper
• Genome-Wide Identification of Host-Segregating Single-Nucleotide Polymorphisms for Source Attribution of Clinical Campylobacter coli Isolates

  2020cites this paper
• Cutaneous vaccination ameliorates Zika virus-induced neuro-ocular pathology via reduction of anti-ganglioside antibodies

  2020cites this paper
• The Frequency of Infection with Campylobacter, Its Species Diversity, and Antimicrobial Resistance in Stool Samples of Patients with Community-Acquired Gastroenteritis in Tehran

  2020cites this paper
• Tracing the animal sources of surface water contamination with Campylobacter jejuni and Campylobacter coli.

  2020cites this paper
• A review of food poisoning caused by local food in Japan

  2020cites this paper
• Pathogen‐specific risk of seizure in children with moderate‐to‐severe diarrhoea: Case control study with follow‐up

  2020cites this paper
• Zika virus-induced neuro-ocular pathology in immunocompetent mice correlates with anti-ganglioside autoantibodies

  2020cites this paper
• Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/endothelial cells

  2020cites this paper
• Proteomics of Campylobacter jejuni Growth in Deoxycholate Reveals Cj0025c as a Cystine Transport Protein Required for Wild-type Human Infection Phenotypes

  2020cites this paper